About 1 in 100 Americans has hyperthyroidism, an excess of thyroid hormone that drives the metabolic engine into overdrive. Patients describe feeling like a wound spring — restless, sweaty, hungry but losing weight, with a heart that races for no reason. The most common cause in the US is Graves’ disease, an autoimmune disorder where antibodies stimulate the thyroid receptor. Toxic multinodular goiter and toxic adenomas account for most of the rest.
Untreated hyperthyroidism is more dangerous than its sluggish counterpart. Cardiac arrhythmias, osteoporosis, weight loss, and thyroid storm can all complicate severe disease. According to the NIDDK, women are five times more likely than men to be affected. This guide covers the three main treatments, the lab traps, and what thyroid storm actually looks like in practice.
What Hyperthyroidism Is
Hyperthyroidism is excessive thyroid hormone production. Thyrotoxicosis is the broader term for excess thyroid hormone in the blood from any source, including non-glandular causes like factitious ingestion or destructive thyroiditis. The clinical syndrome is the same regardless of cause: tachycardia, heat intolerance, weight loss despite increased appetite, tremor, anxiety, insomnia, frequent bowel movements, hair changes, and proximal muscle weakness.
Older patients sometimes present with “apathetic hyperthyroidism” — atrial fibrillation, weight loss, and fatigue without the classic adrenergic features. That subtle picture is easy to miss. For broader context on autoimmune endocrine disease, see our overview of medical conditions.
The Three Common Causes
Graves’ disease accounts for 60 to 80 percent of US hyperthyroidism. Antibodies (TSI, TRAb) bind and stimulate the TSH receptor, driving hormone production and gland growth. Graves’ classically produces diffuse goiter, ophthalmopathy (proptosis, lid lag, periorbital edema), and pretibial myxedema. Smoking sharply worsens Graves’ eye disease.
Toxic multinodular goiter develops in long-standing nodular goiters, particularly in older adults. Individual nodules become autonomous, ignoring TSH regulation. Toxic adenoma is a single autonomously functioning nodule with the same effect. Subacute, postpartum, and silent thyroiditis cause transient hyperthyroidism through gland destruction releasing stored hormone, often followed by a hypothyroid phase before resolution.
Symptoms by Severity
Mild disease may produce only a slight tremor, heat intolerance, and slightly elevated heart rate. Moderate hyperthyroidism brings clear weight loss (often 10 to 20 pounds), tachycardia at rest, anxiety, and insomnia. Severe disease produces atrial fibrillation, heart failure, profound muscle weakness, and visible goiter. About 5 to 10 percent of new-onset atrial fibrillation in adults under 60 is hyperthyroidism-driven.
Untreated long-standing hyperthyroidism causes osteoporosis, particularly in postmenopausal women, due to accelerated bone turnover. T3 is highly catabolic to bone.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience high fever above 102 degrees Fahrenheit with rapid heart rate over 130 beats per minute, severe agitation or confusion with diaphoresis, vomiting and dehydration with known thyroid disease, chest pain with shortness of breath, or seizure — these can signal thyroid storm, which carries up to 25 percent mortality even with prompt treatment.
Lab Diagnosis
TSH is the screening test and is suppressed (typically below 0.1 mIU/L) in overt hyperthyroidism. Free T4 and total T3 confirm the diagnosis and quantify severity. T3 toxicosis — elevated T3 with normal T4 — accounts for 5 to 10 percent of cases, particularly early Graves’ or toxic nodular disease. Subclinical hyperthyroidism shows suppressed TSH with normal free T4 and T3.
Once thyrotoxicosis is confirmed, the next test distinguishes causes. A radioactive iodine uptake (RAIU) scan separates high-uptake conditions (Graves’, toxic nodular goiter) from low-uptake conditions (thyroiditis, exogenous hormone). TSI/TRAb antibodies confirm Graves’ without requiring radiation. Thyroid ultrasound with Doppler is increasingly used as the alternative to RAIU. The American Thyroid Association guidelines outline the diagnostic algorithm in detail.
Antithyroid Drugs
Methimazole and propylthiouracil (PTU) block thyroid hormone synthesis. Methimazole is preferred for most patients — once or twice daily dosing, fewer hepatic side effects. Typical starting doses are 10 to 30 mg/day for moderate disease. PTU is used in the first trimester of pregnancy (methimazole is teratogenic in early pregnancy) and in thyroid storm because it also blocks T4-to-T3 conversion.
Side effects include rash (5 to 10 percent), liver injury (rare but more common with PTU), and agranulocytosis (a sudden drop in white cells, less than 0.5 percent of patients). Patients are warned to stop the medication and seek immediate care for sore throat with fever. About 30 to 50 percent of Graves’ patients achieve remission after 12 to 18 months of antithyroid therapy. The other half relapse and need definitive therapy.
Radioactive Iodine Ablation
Oral radioactive iodine (I-131) destroys overactive thyroid tissue. It’s the most common definitive treatment for Graves’ disease in the US. A single dose typically renders the patient hypothyroid within 6 to 12 months, requiring lifelong levothyroxine — see our hypothyroidism guide for what comes next. RAI is contraindicated in pregnancy and breastfeeding and is generally avoided in moderate-to-severe Graves’ eye disease, since it can worsen ophthalmopathy.
Beta-blockers (propranolol, atenolol) are added in most patients during the early treatment phase to control heart rate, tremor, and anxiety while waiting for definitive therapy or antithyroid drugs to take effect.
Surgery
Total or near-total thyroidectomy is preferred over RAI for patients with very large goiters causing compressive symptoms, suspected thyroid cancer, moderate-to-severe Graves’ eye disease, pregnancy with antithyroid drug intolerance, or patient preference. Surgery in experienced hands has a 1 to 2 percent risk of recurrent laryngeal nerve injury and a similar risk of permanent hypoparathyroidism. Lifelong levothyroxine and calcium/vitamin D monitoring follow.
Graves’ Eye Disease
About a third of Graves’ patients develop clinically apparent ophthalmopathy. The orbital tissues swell and infiltrate with lymphocytes and glycosaminoglycans, pushing the eye forward. Mild cases need lubricants and possibly selenium supplementation. Moderate-to-severe disease — diplopia, vision threat — is treated with IV glucocorticoids, teprotumumab (Tepezza), orbital radiation, or decompressive surgery. Smoking cessation is essential, since smoking dramatically worsens disease activity. Cleveland Clinic has detailed protocols for staging and treating ophthalmopathy.
When to See a Doctor
Unexplained weight loss with increased appetite, persistent tachycardia, hand tremor, heat intolerance, or new atrial fibrillation should prompt thyroid testing. A primary care physician can run TSH and free T4. Endocrinology referral follows confirmed diagnosis for treatment selection. Anyone with eye changes — bulging, double vision, redness — needs ophthalmology involvement alongside endocrinology.
Frequently Asked Questions
Can hyperthyroidism go away on its own?
Subacute and postpartum thyroiditis often resolve spontaneously over weeks to months. Graves’ disease occasionally remits but more often requires treatment. Toxic nodular disease essentially never resolves without intervention, since the autonomous tissue won’t downregulate.
Is hyperthyroidism the same as Graves’ disease?
Graves’ is one cause of hyperthyroidism, accounting for the majority of US cases. The terms are not interchangeable. Toxic multinodular goiter, toxic adenoma, and thyroiditis all cause hyperthyroidism without Graves’ antibodies. See our Graves’ disease guide for detail.
What foods should I avoid with hyperthyroidism?
Iodine excess can worsen disease in some forms — most clinicians advise moderate iodine intake during active hyperthyroidism. Kelp and seaweed supplements, iodine-containing contrast, and amiodarone are particular concerns. Caffeine doesn’t cause the disease but can worsen palpitations.
How long does treatment take to work?
Beta-blockers control heart rate within hours. Antithyroid drugs lower hormone levels over 4 to 8 weeks. RAI takes 2 to 6 months for full effect. Surgery is essentially immediate. Symptom improvement typically lags lab improvement by several weeks.
What to Do Next
If TSH is suppressed and symptoms fit, the diagnostic workflow is well-defined: confirm with free T4 and T3, characterize the cause with antibodies or imaging, and pick a treatment that matches the disease and the patient. Beta-blockers cover the symptoms while definitive therapy gets going. The biggest avoidable harm in hyperthyroidism is delay — months of untreated thyrotoxicosis cause cardiac and bone damage that won’t fully reverse, even after labs normalize.